论文部分内容阅读
被外科医师剔除手术治疗的小细胞肺癌(SCLD)患者的生存期和复发类型不明,为此作者采用全量放疗的这类患者和术前临床分期相同但采用手术治疗的患者作了比较.经细胞学或组织学确诊的SCLC183例,其中治疗前临床分期Ⅰ～Ⅲa期80例,除去拒绝手术或放射剂量<30Gy的患者.接受手术治疗37例,放疗32例.放疗剂量50.2～75.0Gy,平均57.8±6.1Gy.除各组有1例外,均接受化疗.化疗方案为VCMC(长春新碱、环磷酰胺、丝裂霉素C和色霉素A_2)、CAV(环磷酰胺、阿
The survival and recurrence types of patients with small cell lung cancer (SCLD) that were surgically removed by surgeons were unknown. For this reason, the authors compared the use of full-bore radiation therapy with those patients who had the same preoperative clinical stage but were treated surgically. There were 183 cases of SCLC diagnosed by histology or histology, of which 80 cases were pre-treatment clinical stage I-IIIa, and patients who refused surgery or radiation doses <30Gy were excluded. 37 cases received surgical treatment and 32 cases received radiotherapy. The radiation dose was 50.2-75.0Gy. 57.8 ± 6.1 Gy. Except for 1 exception in each group, all received chemotherapy. The chemotherapy regimens were VCMC (vincristine, cyclophosphamide, mitomycin C, and chromomycin A 2), CAV (cyclophosphamide, A